期刊文献+

金水相生法在肺癌化疗中的应用探讨 被引量:16

Investigation on Method of Mutual Promotion Between Lung and Kidney in Lung Cancer Chemotherapy
在线阅读 下载PDF
导出
摘要 化疗是中晚期肺癌最主要的治疗措施,而化疗的毒副反应是其疗效的瓶颈。因此,寻找对化疗减毒增效的药物或方法是当今研究的热点。目前,大多数减轻肺癌化疗副反应的中医治法集中在益气健脾法方面的研究,对于同时固护"先天之本"的肾气研究较少。肺癌化疗后多存在气阴两虚,肾精不足。金水相生法包括了益气养阴、补肺滋肾、填精生髓,有整体调治,减轻化疗毒性反应,增强化疗效果的作用,具有良好的应用前景。 Chemotherapy is the main treatment for mid - term and advanced lung cancer. The toxicity of chemotherapy is the bottleneck of its efficacy. Therefore, it is a hot research today to find out a drug or method of chemotherapy attenua- ted efficiency. Currently, most TCM treatments of reducing side effects of chemotherapy in lung cancer concentrate on re- plenishing qi to invigorate the spleen. Current research on the protection of the kidney as the foundation of innateness is less. There is more lack of kidney essence insufficiency after chemotherapy for lung cancer. The method of mutual promotion between lung and kidney includes supplementing qi and nourishing yin, supplementing lung and nourishing kidney, filling precision and producing intramedullary. This therapy has a role in overall modulating, reducing toxicity of chemotherapy and enhancing the effect of chemotherapy with a good prospect.
出处 《中华中医药学刊》 CAS 北大核心 2017年第11期2780-2782,共3页 Chinese Archives of Traditional Chinese Medicine
基金 国家自然科学基金青年科学基金项目(81403300) 广东省科技计划项目(2014A020212180) 南方医科大学科研启动计划青年科技人员培育项目(PY2013N057)
关键词 肺癌 化疗 中医药疗法 lung cancer chemotherapy Chinese medicine
作者简介 师林(1983-),女,陕西临潼人,副主任医师,硕士,研究方向:中医肿瘤研究。 通讯作者:柯斌(1983-),男,湖北丹江口人,主治医师,博士,研究方向:中医肿瘤研究。E-mail:jackhorn@163.com。
  • 相关文献

参考文献13

二级参考文献154

共引文献113

同被引文献259

引证文献16

二级引证文献87

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部